Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05987540 · ClinicalTrials.gov registry record · NA
SHARPEN - Parkinson's Disease Dementia
A NA study, sponsored by Scion NeuroStim.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT05987540 is a NA study that was terminated before completion, run by Scion NeuroStim. The registered enrollment target is 9 participants.
The verdict
NCT05987540, a NA study, was terminated before completion, sponsored by Scion NeuroStim.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this single arm study is to evaluate the feasibility and safety of treatments with a non-invasive neuromodulation device in adults diagnosed with mild/moderate Parkinson's disease dementia (PDD). A non-invasive device is a device that stays outside of the body and is not implanted and does not penetrate the skin. Neuromodulation means that the device stimulates activity in the brain.
Interventions
- DEVICE Non-invasive brainstem stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2024-05-08 |
| Est. Completion | 2025-02-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05987540
The ClinicalTrials.gov registry entry for NCT05987540 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scion NeuroStim, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-invasive brainstem stimulation is the first listed.
NCT05987540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05987540 about?
NCT05987540 is a clinical study titled "SHARPEN - Parkinson's Disease Dementia". The purpose of this single arm study is to evaluate the feasibility and safety of treatments with a non-invasive neuromodulation device in adults diagnosed with mild/moderate Parkinson's disease dementia (PDD). A non-invasive device is a device that stays outside of the body and is not implanted and...
What is the current status of trial NCT05987540?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2024-05-08. Estimated completion is 2025-02-24.
What interventions are being tested in trial NCT05987540?
The interventions under investigation include: Non-invasive brainstem stimulation (DEVICE).
Who is sponsoring clinical trial NCT05987540?
This trial is sponsored by Scion NeuroStim, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.